Annual report pursuant to Section 13 and 15(d)

STATEMENTS OF STOCKHOLDERS' EQUITY

v3.20.4
STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2018 4,610,109      
Beginning balance, amount at Dec. 31, 2018 $ 14,000 $ 48,325,000 $ (55,133,000) $ (6,794,496)
Initial public offering of common stock, net of issuance costs (Note 7), shares 2,272,727      
Initial public offering of common stock, net of issuance costs (Note 7), amount $ 2,000 22,456,000   22,458,000
Automatic conversion of convertible debt to common stock (Note 6), shares 1,475,164      
Automatic conversion of convertible debt to common stock (Note 6), amount $ 2,000 13,791,000   13,793,000
Beneficial conversion feature (Note 5)   7,067,000   7,067,000
Common stock issued for Framerate Acquisition (Note 5), shares 134,422      
Common stock issued for Framerate Acquisition (Note 5), amount   1,000,000   1,000,000
Framerate Earn-Out (Note 5)   454,000   454,000
Stock-based compensation, shares 14,833      
Stock-based compensation, amount   6,124,000   6,124,000
Stock option and warrant exercises, shares 66,667      
Stock option and warrant exercises, amount   20,000   20,000
Net loss (30,679,000) (30,679,000)
Ending balance, shares at Dec. 31, 2019 8,573,922      
Ending balance, amount at Dec. 31, 2019 $ 18,000 99,237,000 (85,812,000) 13,443,000
Issuance of common stock at $3.50 per share, net of issuance costs (Note 7), shares 1,825,000      
Issuance of common stock at $3.50 per share, net of issuance costs (Note 7), amount $ 2,000 5,951,000   5,953,000
Issuance of common stock at $1.85 per share, net of issuance costs (Note 7), shares 4,988,981      
Issuance of common stock at $1.85 per share, net of issuance costs (Note 7), amount $ 5,000 8,398,000   8,403,000
Common stock issued for Framerate Acquisition (Note 5), shares 32,936      
Common stock issued for Framerate Acquisition (Note 5), amount       0
Stock-based compensation, shares 62,171      
Stock-based compensation, amount   1,863,000   1,863,000
Stock option and warrant exercises, shares 0      
Stock option and warrant exercises, amount   10,000   10,000
Net loss (18,732,000) (18,732,000)
Ending balance, shares at Dec. 31, 2020 15,483,010      
Ending balance, amount at Dec. 31, 2020 $ 25,000 $ 115,459,000 $ (104,544,000) $ 10,940,000